ACCESSION: MSBNK-SMB_Measured-HSA015P0125000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL01_pos_2801': {'bp': 238100.0, 'sum': 800277.0}, 'EL23_pos_2807': {'bp': 237231.0, 'sum': 718223.0}, 'EL15_pos_2606': {'bp': 230798.0, 'sum': 716173.0}, 'EL16_pos_2786': {'bp': 217261.0, 'sum': 695725.0}, 'EL24_pos_2824': {'bp': 201368.0, 'sum': 655440.0}, 'EL04_pos_2813': {'bp': 199606.0, 'sum': 662344.0}, 'EL02_pos_2806': {'bp': 188922.0, 'sum': 740483.0}, 'EL08_pos_2795': {'bp': 187246.0, 'sum': 676083.0}, 'EL09_pos_2788': {'bp': 186528.0, 'sum': 658992.0}, 'EL06_pos_2795': {'bp': 184790.0, 'sum': 651662.0}, 'EL22_pos_2806': {'bp': 183966.0, 'sum': 724924.0}, 'EL14_pos_2795': {'bp': 182880.0, 'sum': 671799.0}, 'EL07_pos_2792': {'bp': 180356.0, 'sum': 651520.0}, 'EL13_pos_2795': {'bp': 176430.0, 'sum': 652213.0}, 'EL19_pos_2813': {'bp': 168748.0, 'sum': 635649.0}, 'EL18_pos_2800': {'bp': 168714.0, 'sum': 675386.0}, 'EL17_pos_2794': {'bp': 156536.0, 'sum': 636933.0}, 'EL11_pos_2787': {'bp': 153955.0, 'sum': 597622.0}, 'EL21_pos_2617': {'bp': 150059.0, 'sum': 571674.0}, 'EL20_pos_2618': {'bp': 142963.0, 'sum': 581544.0}, 'EL17_pos_2624': {'bp': 142142.0, 'sum': 623912.0}, 'EL12_pos_2783': {'bp': 142084.0, 'sum': 569462.0}, 'EL19_pos_2648': {'bp': 133386.0, 'sum': 586281.0}, 'EL23_pos_2647': {'bp': 117052.0, 'sum': 576919.0}}
COMMENT: RETENTION_TIME_STDEV 0.121
COMMENT: PRECURSOR_M/Z_RAW 125.107605
COMMENT: PRECURSOR_M/Z_STDEV 0.000035
COMMENT: PRECURSOR_IN_MS1 mz 125.107302; int 47.289; delta(ppm) 0.687659
COMMENT: PROPOSED_CHARGE_STATE +1; mz 126.110632; int 3.632; cor 0.706
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.153; C7H12N2; [M+H]+; delta(ppm) -0.153102
COMMENT: PROPOSED_MF MS-FINDER 3.506; C7H12N2; [M+H]+; delta(ppm) -0.158500
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.518; C7H12N2; [M+H]+; delta(ppm) -0.158500
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) -0.158500
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.907; C7H12N2; [M+H]+; delta(ppm) -0.158500
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N2; [M+H]+; delta(ppm) -0.158500
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.742; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; CCCCC1=NC=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.432; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; CCN1CN(C=C1)C=C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.641; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.391; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.962; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.892; SGUVLZREKBPKCE-UHFFFAOYSA-N; [M+H]+; 2,3,4,6,7,8-hexahydropyrrolo[1,2-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.619; MCMFEZDRQOJKMN-UHFFFAOYSA-N; [M+H]+; 1-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.940; SLLDUURXGMDOCY-UHFFFAOYSA-N; [M+H]+; 2-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.759; HUMMCZRNZCKXHL-UHFFFAOYSA-N; [M+H]+; 1-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.652; CLVBVRODHJFTGF-UHFFFAOYSA-N; [M+H]+; 2-piperidin-1-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.617; PDVYZQGNSCSKPG-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; OZLQTEIBZXQTLQ-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-2-(methylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.310; UVQPDGXQIPNYNU-UHFFFAOYSA-N; [M+H]+; 1-ethenyl-3-ethyl-2H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.280; HZJOVDAZLMBPPZ-UHFFFAOYSA-N; [M+H]+; 2-piperidin-3-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.261; IEGLIUHTOPMAFW-UHFFFAOYSA-N; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.203; GDRRCHJTUJBMQA-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-propan-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.198; YIDCITOHTLPMMZ-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.179; JYOKDJPITDWCEZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; KLKXWOZRCZWLNA-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidine-3-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.161; IJRFANCSEQXUNT-UHFFFAOYSA-N; [M+H]+; 2-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; BVGQGPWKBMTPNM-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-propyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; KNIPASVZFLFVSD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.136; RVGOKHBYNZPVGI-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; QOLDCHQHOOFRGQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; GFJCGXFXOXSUJX-UHFFFAOYSA-N; [M+H]+; 5-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.124; SWEZGJVIOFBJBX-UHFFFAOYSA-N; [M+H]+; 5-methyl-4-propan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; KMUHAJOXPNPERW-UHFFFAOYSA-N; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; AMQKPABOPFXDQM-UHFFFAOYSA-N; [M+H]+; 1-tert-butylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; NKYDATLMFPYEJM-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropyl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; IYTBULKZSACADZ-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopentane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; WOPVVVYENHYREL-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclopentylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; VIXYONLJAGTTOD-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; XMTHAWZPEGHZPK-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; GWCSATTUAOHJDK-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; UFLLSVUGUWBXJA-UHFFFAOYSA-N; [M+H]+; 3,5-diethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; BJIDGKXFJLYGNA-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; MGSZBMLUKBKFIH-UHFFFAOYSA-N; [M+H]+; 4-ethyl-3,5-dimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; QUSOBKIKODRYSH-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; UGOZVQRJDQYTKT-UHFFFAOYSA-N; [M+H]+; N-methyl-2-pyrrol-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; GUFHZYGWUDAKJR-UHFFFAOYSA-N; [M+H]+; (5-ethyl-1H-pyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; WLUJHMKCLOIRSK-UHFFFAOYSA-N; [M+H]+; 1,2,4,5-tetramethylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.937; CTUNHIMNHSKDBN-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; IGSGRZGYPSFKAS-UHFFFAOYSA-N; [M+H]+; 4-butan-2-yl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; ITFDYXKCBZEBDG-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; LOCUKVKZMLTDJC-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrrol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; ZVTFIBQPABQXLK-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-ylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; KJENYXWFEZWBBS-UHFFFAOYSA-N; [M+H]+; (2,5-dimethyl-1H-pyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; MXDKDPXBTLQXNF-RNFRBKRXSA-N; [M+H]+; 2-[(1S,3R)-3-aminocyclopentyl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; ITGMTNOYOPHQAE-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; CNRYJJXBFLHSJP-UHFFFAOYSA-N; [M+H]+; 3-pyrrol-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; ULKZTFQDSPKNMV-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.556; SFRZJVGGJFNWHZ-UHFFFAOYSA-N; [M+H]+; 4-tert-butyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -83.168; MCMFEZDRQOJKMN; [M+H]+; N-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -100.785; PDVYZQGNSCSKPG; [M+H]+; 1-Pyrrolidinepropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.980; GWCSATTUAOHJDK; [M+H]+; Ambcb4040562
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.270; IEGLIUHTOPMAFW; [M+H]+; 1-(2-isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.757; SGUVLZREKBPKCE; [M+H]+; 1,5-Diazabicyclo[4.3.0]-5-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.244; SLLDUURXGMDOCY; [M+H]+; 2-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.523; KVMUMGRJMXZCMW; [M+H]+; 2-Ethyl-5,6-dihydro-3-methylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.700; CLVBVRODHJFTGF; [M+H]+; Piperidoacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.747; CNRYJJXBFLHSJP; [M+H]+; Ambcb4027319
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.188; CTUNHIMNHSKDBN; [M+H]+; Ambcb4039818
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.142; ZVTFIBQPABQXLK; [M+H]+; piperidinylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.740; YVYGFQPWNRTJNS; [M+H]+; 2,3,5-Trimethyl-5,6-dihydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.657; OKDQKPLMQBXTNH; [M+H]+; Pyridinamine,N,N-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.430; ITFDYXKCBZEBDG; [M+H]+; 1-Methyl-1H-pyrrole-2-ethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.267; RFXJLECGYGFJCI; [M+H]+; Ambcb4039941
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.509; HQOXLKBFOCPYAE; [M+H]+; 5,7-dimethyl-2,3-dihydro-1H-1,4-diazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -228.367; XMTHAWZPEGHZPK; [M+H]+; 1-(1H-pyrrol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.792; HUMMCZRNZCKXHL; [M+H]+; Ambcb4036030
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.349; WLUJHMKCLOIRSK; [M+H]+; 1,2,4,5-Tetramethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.454; KMUHAJOXPNPERW; [M+H]+; (1,5-dimethylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.224; GFJCGXFXOXSUJX; [M+H]+; 3-Butylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -313.468; YIDCITOHTLPMMZ; [M+H]+; Bionet2_000181
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.462; MCMFEZDRQOJKMN; [M+H]+; N-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.522; AMQKPABOPFXDQM; [M+H]+; 1-t-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.988; MCMFEZDRQOJKMN; [M+H]+; 1-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.141; UVQPDGXQIPNYNU; [M+H]+; 3-Ethenyl-1-ethyl-1,2-dihydroimidazol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -104.174; YVYGFQPWNRTJNS; [M+H]+; 2,3-Dihydro-2,5,6-trimethylpyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -104.748; RFXJLECGYGFJCI; [M+H]+; 2-(2-Methylpropyl)-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.327; SLLDUURXGMDOCY; [M+H]+; 2-Butylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.191; WLUJHMKCLOIRSK; [M+H]+; 2-(Deuteriomethyl)-1,4,5-trimethylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.128; CTUNHIMNHSKDBN; [M+H]+; 2-tert-butyl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.116; IEGLIUHTOPMAFW; [M+H]+; 1-(2-Isocyanoethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.954; GWCSATTUAOHJDK; [M+H]+; 1-(Prop-2-yn-1-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.262; AMQKPABOPFXDQM; [M+H]+; 1-t-Butylimidazole
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.450
MS$FOCUSED_ION: PRECURSOR_M/Z 125.107305
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0059-5900000000-6de40970f4262bb3727f
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388112 24.5828 53.039509 1.1690 5.27 0.1957 23 f{C4H5}/4.42ppm,p-C3H8N2
  55.0544570 32.2197 55.055165 0.8537 9.84 -0.0208 21 f{C4H7}/4.18ppm,p-C3H6N2
  56.0497183 24.4330 56.050430 1.0526 15.04 -0.0536 22 f{C3H6N1}/4.33ppm,p-C4H7N1
  56.9650023 21.6259 56.965718 1.0006 6.36 0.1453 23 ?
  57.0700591 20.2638 57.070776 1.2441 5.77 0.0506 18 f{C4H9}/3.20ppm,p-C3H4N2
  58.0653747 44.8153 58.066095 1.1366 12.82 0.6165 20 f{C3H8N1}/4.29ppm,p-C4H5N1
  67.0543580 35.5541 67.055099 0.8948 10.56 -0.1361 22 f{C5H7}/1.96ppm,p-C2H6N2
  67.9349913 15.7934 67.935734 1.2070 4.76 -0.0423 22 ?
  68.0495713 17.3498 68.050314 0.9258 6.36 -0.2947 19 f{C4H6N1}/1.41ppm,p-C3H7N1
  70.0652114 17.8686 70.065955 1.1561 4.83 0.1333 19 f{C4H8N1}/1.22ppm,p-C3H5N1
  71.9519212 15.3992 71.952664 1.3759 3.09 0.3838 17 ?
  79.0543242 55.6204 79.055056 1.2144 13.54 0.0243 22 f{C6H7}/1.23ppm,p-C1H6N2
  80.0495501 103.3067 80.050280 0.7995 37.69 0.3983 24 f{C5H6N1}/0.93ppm,p-C2H7N1
  81.0699174 72.0268 81.070644 0.7648 19.63 -0.1843 24 f{C6H9}/0.50ppm,p-C1H4N2
  82.0650636 24.2220 82.065787 0.8652 10.97 -0.0960 18 f{C5H8N1}/-0.76ppm,p-C2H5N1
  82.9418901 24.0582 82.942610 1.4589 4.94 0.2721 17 ?
  83.0604376 235.8514 83.061157 0.4093 19.86 0.8391 24 f{C4H7N2}/0.76ppm,p-C3H6
  84.0808155 106.6506 84.081531 0.7255 26.38 0.8872 20 f{C5H10N1}/0.47ppm,p-C2H3N1
  84.9597411 314.6221 84.960453 0.4002 60.13 0.0409 24 ?
  96.0444044 64.1377 96.045050 1.2598 15.93 -0.1759 23 ?
  96.0807346 21.6007 96.081379 0.9367 14.35 -0.4715 22 f{C6H10N1}/-0.43ppm,p-C1H3N1
  98.0600474 15.8584 98.060676 1.4073 5.52 0.0000 17 ?
  102.9703029 29.3152 102.970888 0.9420 7.93 -0.0889 23 ?
  108.0444411 153.4818 108.044977 0.6571 99.06 -0.0241 20 ?
  109.0760621 35.7683 109.076591 0.9351 14.09 0.0762 22 f{C6H9N2}/0.34ppm,p-C1H4
  110.0839013 108.4656 110.084423 0.6813 40.76 0.1757 24 f{C6H10N2}/0.47ppm,p-C1H3
  118.9630010 20.9157 118.963450 1.0255 7.24 -0.1993 22 ?
  123.0552947 61.2774 123.055704 0.9914 16.23 0.2900 18 ?
  124.0393928 121.3074 124.039793 0.7175 31.95 -0.2157 24 ?
  124.0756565 84.3753 124.076056 1.0155 23.79 0.0017 24 ?
  124.1120106 17.2019 124.112410 1.3536 6.62 -0.3498 23 ?
  125.0598398 36.3804 125.060229 0.9356 13.11 -0.5501 18 ?
  125.0709398 58.8570 125.071329 0.9275 40.64 -0.2426 24 ?
  125.1073389 999.0000 125.107727 0.3677 0.00 1.0000 24 f{C7H13N2}/0.11ppm,p
  126.0549343 40.2849 126.055313 1.0630 10.17 0.2104 24 ?
  126.0912947 150.9985 126.091673 0.9517 99.24 0.3904 24 ?
  126.1108987 85.9774 126.111277 1.0308 9.84 0.8278 24 ?
  127.0390129 28.0576 127.039381 1.4248 9.10 0.0069 23 ?
  127.1229552 50.0198 127.123322 1.3530 14.13 0.5144 22 ?
PK$NUM_PEAK: 39
PK$PEAK: m/z int. rel.int.
  53.038811 24.58 24
  55.054457 32.22 32
  56.049718 24.43 24
  56.965002 21.63 21
  57.070059 20.26 20
  58.065375 44.82 44
  67.054358 35.55 35
  67.934991 15.79 15
  68.049571 17.35 17
  70.065211 17.87 17
  71.951921 15.40 15
  79.054324 55.62 55
  80.049550 103.31 103
  81.069917 72.03 72
  82.065064 24.22 24
  82.941890 24.06 24
  83.060438 235.85 235
  84.080816 106.65 106
  84.959741 314.62 314
  96.044404 64.14 64
  96.080735 21.60 21
  98.060047 15.86 15
  102.970303 29.32 29
  108.044441 153.48 153
  109.076062 35.77 35
  110.083901 108.47 108
  118.963001 20.92 20
  123.055295 61.28 61
  124.039393 121.31 121
  124.075656 84.38 84
  124.112011 17.20 17
  125.059840 36.38 36
  125.070940 58.86 58
  125.107339 999.00 999
  126.054934 40.28 40
  126.091295 151.00 150
  126.110899 85.98 85
  127.039013 28.06 28
  127.122955 50.02 50
//
